The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective phase II trial of neoadjuvant nivolumab plus gemcitabine/cisplatin chemotherapy in muscle-invasive urothelial carcinoma of bladder.
 
Hongsik Kim
No Relationships to Disclose
 
Ryul Kim
No Relationships to Disclose
 
Joohyun Hong
No Relationships to Disclose
 
Ghee Young Kwon
No Relationships to Disclose
 
Chan Kyo Kim
No Relationships to Disclose
 
Won Park
No Relationships to Disclose
 
Wan Song
No Relationships to Disclose
 
Hyun Hwan Sung
No Relationships to Disclose
 
Byong Chang Jeong
No Relationships to Disclose
 
Jung Yong Hong
No Relationships to Disclose
 
Se Hoon Park
Honoraria - Merck; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Janssen Oncology
Research Funding - Ono Pharmaceutical; Sanofi